F Rogowski

489 total citations
43 papers, 334 citations indexed

About

F Rogowski is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, F Rogowski has authored 43 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 13 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in F Rogowski's work include Thyroid Cancer Diagnosis and Treatment (9 papers), Thyroid Disorders and Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). F Rogowski is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (9 papers), Thyroid Disorders and Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). F Rogowski collaborates with scholars based in Poland, Russia and Austria. F Rogowski's co-authors include Piotr Szumowski, E Chyczewska, L Chyczewski, Jacek Nikliński, M Furman, Ewa Jabłońska, J Laudański, Anna Gromotowicz‐Poplawska, Adrian Stankiewicz and Janusz Szemraj and has published in prestigious journals such as European Respiratory Journal, Calcified Tissue International and Clinical Chemistry and Laboratory Medicine (CCLM).

In The Last Decade

F Rogowski

42 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Rogowski Poland 11 99 88 75 64 51 43 334
Michiyo Ishii Japan 11 97 1.0× 105 1.2× 100 1.3× 48 0.8× 67 1.3× 23 430
Isao UCHIMURA Japan 12 96 1.0× 55 0.6× 129 1.7× 38 0.6× 77 1.5× 27 539
Olga Bloch Israel 13 93 0.9× 86 1.0× 82 1.1× 32 0.5× 31 0.6× 24 331
Hugh E. Black United States 12 74 0.7× 64 0.7× 118 1.6× 52 0.8× 18 0.4× 30 419
Takeo Nishimori Japan 12 68 0.7× 43 0.5× 72 1.0× 54 0.8× 33 0.6× 29 490
Chul Han Kim South Korea 10 50 0.5× 69 0.8× 84 1.1× 47 0.7× 59 1.2× 26 336
Rachel H. Bonami United States 12 115 1.2× 104 1.2× 89 1.2× 22 0.3× 53 1.0× 30 543
Valērija Groma Latvia 12 36 0.4× 50 0.6× 76 1.0× 50 0.8× 82 1.6× 53 385
Giorgio Caratti Germany 10 101 1.0× 41 0.5× 131 1.7× 57 0.9× 43 0.8× 14 468
T Aizawa Japan 9 91 0.9× 241 2.7× 127 1.7× 40 0.6× 79 1.5× 21 391

Countries citing papers authored by F Rogowski

Since Specialization
Citations

This map shows the geographic impact of F Rogowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Rogowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Rogowski more than expected).

Fields of papers citing papers by F Rogowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Rogowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Rogowski. The network helps show where F Rogowski may publish in the future.

Co-authorship network of co-authors of F Rogowski

This figure shows the co-authorship network connecting the top 25 collaborators of F Rogowski. A scholar is included among the top collaborators of F Rogowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Rogowski. F Rogowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Szumowski, Piotr, et al.. (2013). Parathyroid gland function after radioiodine (131I) therapy for toxic and non-toxic goitre. Endokrynologia Polska. 64(5). 340–345. 7 indexed citations
3.
Szumowski, Piotr, et al.. (2012). Iodine isotope (131I) therapy for toxic nodular goitre: treatment efficacy parameters. Nuclear Medicine Review. 15(1). 7–13. 22 indexed citations
4.
Szumowski, Piotr, et al.. (2012). Bone scan in metabolic bone diseases. Review.. PubMed. 15(2). 124–31. 14 indexed citations
5.
Szumowski, Piotr, et al.. (2012). Iodine isotope (131I) therapy for toxic nodular goitre: treatment efficacy parameters. Nuclear Medicine Review. 15(1). 7–13. 13 indexed citations
6.
7.
Bossowski, Artur, et al.. (2010). Relationship between Metabolic Parameters and Thyroid Hormones and the Level of Gastric Peptides in Children with Autoimmune Thyroid Diseases. Journal of Pediatric Endocrinology and Metabolism. 23(4). 345–54. 19 indexed citations
8.
Jabłońska, Ewa, et al.. (2008). TRAIL receptors in the serum of patients with B-cell chronic lymphocytic leukemia.. PubMed. 55(1). 51–4. 2 indexed citations
9.
Jabłońska, Ewa, et al.. (2006). [Nitric oxide in supernatants of leukocytes and the serum of patients with B-CLL].. PubMed. 63(12). 1286–90. 1 indexed citations
10.
Chorąży, Monika, et al.. (2006). [Brain perfusion disturbances in patients with vertigo -- a study with SPECT].. PubMed. 39(6). 439–44. 2 indexed citations
11.
Jabłońska, Ewa, et al.. (2005). TNF family molecules in the serum of patients with B-cell chronic lymphocytic leukemia (B-CLL). Leukemia & lymphoma. 46(9). 1307–1312. 15 indexed citations
12.
Rogowski, F, et al.. (2004). [Interleukin-6 and interleukin-12 blood levels in patients with chronic B-cell lymphocytic leukemia].. PubMed. 16(92). 157–61. 1 indexed citations
13.
Rogowski, F, et al.. (2002). E-selectin, L-selectin, ICAM-1 and IL-6 concentrations changes in the serum of patients with hyperthyroidism in the early period of radioiodine I-131 therapy.. Dialnet (Universidad de la Rioja). 5(1). 24–28. 4 indexed citations
14.
Bossowski, Artur, et al.. (2000). Serum Levels of Adhesion Molecules in Children and Adolescents with Immune and Non-immune Thyroid Diseases. Journal of Pediatric Endocrinology and Metabolism. 13(8). 1067–72. 2 indexed citations
15.
Citko, Anna, et al.. (1997). Concentration of the Cross-Linked Carboxyterminal Telopeptide of type I Collagen in Serum of Young Growing Rats Fed a Low Calcium and Vitamin D-Deficient Diet. Clinical Chemistry and Laboratory Medicine (CCLM). 35(12). 915–8. 3 indexed citations
16.
Nikliński, Jacek, M Furman, E Chyczewska, et al.. (1995). Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer. European Respiratory Journal. 8(2). 291–294. 45 indexed citations
17.
Nikliński, Jacek, M Furman, E Chyczewska, et al.. (1994). Evaluation of CYFRA 21–1 as a new marker for non-small cell lung cancer. European Journal of Cancer Prevention. 3(2). 227–230. 20 indexed citations
18.
Nikliński, Jacek, et al.. (1994). [Cyfra 21-1 new marker for non-small cell lung cancer].. PubMed. 62(5-6). 227–32. 1 indexed citations
19.
Jurkowska, Graźyna, et al.. (1992). [Value of plasma testosterone, carcinoembryonic antigen and CA 19-9 in the differential diagnosis of pancreatic carcinoma and chronic pancreatitis].. PubMed. 88(5). 302–9. 2 indexed citations
20.
Badurski, J, et al.. (1991). Chondroprotective action of salmon calcitonin in experimental arthropathies. Calcified Tissue International. 49(1). 27–34. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michiyo Ishii Breakdown of academic impact, for papers by Isao UCHIMURA Breakdown of academic impact, for papers by Olga Bloch Breakdown of academic impact, for papers by Hugh E. Black Breakdown of academic impact, for papers by Takeo Nishimori Breakdown of academic impact, for papers by Chul Han Kim Breakdown of academic impact, for papers by Rachel H. Bonami Breakdown of academic impact, for papers by Valērija Groma Breakdown of academic impact, for papers by Giorgio Caratti Breakdown of academic impact, for papers by T Aizawa
Rankless by CCL
2026